Table 1.
Detection rates (%) of all respiratory viruses among the received respiratory samples by age patient groups
| Age group |
Age (years) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0–4 years |
5–14 years |
15–65 years |
>65 years |
Total (%) | Mean ± SD | Median [IQR] | |||||
| 11 | 2 | 1 | 2 | 1 | 2 | 1 | 2 | ||||
| Samples received | 1881 (30%) | 1601 (25%) | 2483 (39%) | 339 (5%) | 63042 | 21.8 ± 22.0 | 12.0 [3.0–37.0] | ||||
| Positive samples | 1378 | 1099 | 1432 | 155 | 4064 (64%) | 19.1 ± 20.6 | 10.0 [3.0–32.0] | ||||
| 34% | 73% | 27% | 69% | 35% | 58% | 4% | 46% | ||||
| Single detection | 1043 (76%) | 938 (85%) | 1269 (89%) | 137 (88%) | 3387 (83%) | 20.0 ± 20.8 | 11.0 [3.0–33.0] | ||||
| Multiple detection | 335 (24%) | 161 (15%) | 163 (11%) | 18 (12%) | 677 (17%) | 14.1 ± 18.7 | 5.0 [2.0–19.0] | ||||
| Single or multiple respiratory virus infection | |||||||||||
| FLUAV | 394 | 528 | 634 | 43 | 1599 (25%) | 20.0 ± 19.2 | 12.0 [5.0–33.0] | ||||
| 25% | 21% | 33% | 33% | 40% | 26% | 3% | 13% | ||||
| Seasonal H1 | 42 | 33 | 57 | 1 | 133 (2%) | 18.1 ± 17.6 | 9.0 [3.0–30.0] | ||||
| 32% | 2% | 25% | 2% | 43% | 2% | 1% | <1% | ||||
| H1pdm09 | 113 | 272 | 246 | 1 | 632 (10%) | 18.2 ± 16.3 | 12.0 [6.0–29.0] | ||||
| 18% | 6% | 43% | 17% | 39% | 10% | <1% | <1% | ||||
| H3 | 218 | 206 | 302 | 40 | 766 (12%) | 21.9 ± 21.5 | 12.0 [4.0–36.0] | ||||
| 28% | 12% | 27% | 13% | 39% | 12% | 5% | 12% | ||||
| Unsubtyped | 21 | 17 | 29 | 1 | 68 (1%) | 19.4 ± 18.6 | 11.5 [3.0–33.0] | ||||
| 31% | 1% | 25% | 1% | 43% | 1% | 1% | <1% | ||||
| FLUBV | 103 | 255 | 147 | 20 | 525 (8%) | 17.4 ± 18.7 | 9.0 [5.0–25.0] | ||||
| 20% | 5% | 49% | 16% | 28% | 6% | 4% | 6% | ||||
| FLUCV | 9 | 3 | 7 | 0 | 19 (<1%) | 16.6 ± 18.8 | 10.0 [1.0–35.0] | ||||
| 47% | <1% | 16% | <1% | 37% | <1% | 0% | <1% | ||||
| HAdV | 343 | 117 | 110 | 11 | 581 (9%) | 10.9 ± 16.6 | 3.0 [1.0–11.0] | ||||
| 59% | 18% | 20% | 7% | 19% | 4% | 2% | 3% | ||||
| HCoV | 57 | 27 | 100 | 15 | 199 (3%) | 28.2 ± 24.5 | 25.0 [3.0–48.0] | ||||
| 29% | 3% | 14% | 2% | 50% | 4% | 8% | 4% | ||||
| HEV | 110 | 45 | 49 | 5 | 209 (3%) | 13.2 ± 18.1 | 4.0 [2.0–18.0] | ||||
| 53% | 6% | 22% | 3% | 23% | 2% | 2% | 1% | ||||
| HPIV-1 | 45 | 12 | 22 | 2 | 81 (1%) | 14.7 ± 19.2 | 4.0 [2.0–24.0] | ||||
| 56% | 2% | 15% | 1% | 27% | 1% | 2% | 1% | ||||
| HPIV-2 | 48 | 37 | 49 | 5 | 139 (2%) | 19.0 ± 20.0 | 11.0 [3.0–34.0] | ||||
| 35% | 3% | 27% | 2% | 35% | 2% | 4% | 1% | ||||
| HPIV-3 | 55 | 24 | 25 | 5 | 109 (2%) | 15.9 ± 21.6 | 4.0 [2.0–23.0] | ||||
| 50% | 3% | 22% | 1% | 23% | 1% | 5% | 1% | ||||
| HPIV-4 | 30 | 17 | 26 | 3 | 76 (1%) | 18.9 ± 20.7 | 7.5 [2.0–37.0] | ||||
| 39% | 2% | 22% | 1% | 34% | 1% | 4% | 1% | ||||
| HRSV | 243 | 42 | 71 | 8 | 364 (6%) | 11.3 ± 18.2 | 3.00 [1.0–11.0] | ||||
| 67% | 13% | 12% | 3% | 20% | 3% | 2% | 2% | ||||
| HRV | 307 | 158 | 359 | 58 | 882 (14%) | 22.8 ± 23.1 | 13.0 [3.0–39.0] | ||||
| 35% | 16% | 18% | 10% | 41% | 14% | 7% | 17% | ||||
Abbreviations: FLUCV, human influenza C virus; HAdV, human adenoviruses; HCoV, human coronaviruses; HEV, human enteroviruses; HPIV 1–4, human parainfluenza viruses 1, 2, 3 and 4; HRV, human rhinoviruses; IQR, interquartile range.
1
1. Detection rate per age group (% of row); 2. Detection rate per total received samples within each age group (% of column).
2
Missing data: 11 cases.